Dynamic Biotechnology & Genome Invesco ETF (PBE)
$55.79 0.21 (0.38%)
15:17 EST PBE Stock Quote Delayed 15 Minutes
Previous Close $55.58
Market Cap 276.16M
PE Ratio -
Volume (Avg. Vol.) 4,982
Day's Range 55.70 - 55.83
52-Week Range 45.74 - 57.60
Dividend & Yield 0.00 (0.00%)
PBE Stock Predictions, Articles, and Dynamic Biotechnology & Genome Invesco ETF News
- From InvestorPlace
- From the Web
The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.
Amid ongoing industry consolidation, attractive valuations and a strong broad market, catalysts are in place for more upside for biotech ETFs.
Finding the best ETFs to buy can be trying, particularly with the universe of smart beta funds rapidly expanding. These funds, however, beat even their benchmarks.
After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out
Let's take a look Inside four heavily losing ETFs in the year-to-date frame.